October 10, 2025: Ozempic Vision Loss MDL Hearing Scheduled for December A hearing has been scheduled for December that could help decide whether GLP-1 vision loss lawsuits will be grouped together in federal court
Tirzepatide is also the only incretin medication FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity
Frequently Asked Questions How long do I need to hold GLP-1 drops under my tongue
The program includes unlimited telehealth visits, free 2-day shipping, and requires no insurance
Signs, symptoms, and functions reported by pALS included neuromuscular, bulbar, speech, neurocognitive, fatigue, respiration, autonomic, pain, and a range of physical functioning issues
Tissue Cell (2016) 48(1):107